Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

NCT02945280 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

52

Enrollment

OTHER

Sponsor class

Stopped COVID-19 resource allocation

Conditions

Deep Venous Thrombosis
Upper Extremity Deep Venous Thrombosis
Thrombus
Venous Thromboembolism
Deep Vein Thrombosis

Interventions

DRUG: apixaban

Sponsor

Intermountain Health Care, Inc.